What Are The Symptoms of Pulmonary Lymphoma?

This entry looks at pulmonary lymphoma, a lymphoma subtype. 'Lymphoma' is an umbrella term that loosely refers to several dozen independent categorical types and subtypes of cancers of the lymphatic system.

What is Pulmonary Lymphoma?

Primary pulmonary lymphoma refers to a B-cell, non-Hodgkin lymphoma that develops as a single tumor mass in one or both lungs and is generally not found to have spread outside the lungs. It is sometimes misdiagnosed as either an abscess or as non-small cell lung cancer.

In most cases, pulmonary lymphoma is classified as a low-grade (indolent) B-cell non-Hodgkin's lymphoma that develops in mucosa-associated lymphoid tissue (MALT). However, as many as twenty percent of cases are high-grade pulmonary lymphoma and present as an extremely aggressive disease. This aggressive type is more commonly found in patients who are immunocompromised.

How Common is Pulmonary Lymphoma?

Primary pulmonary lymphoma is a very, very rare disease. It accounts for about one half of one percent of all lung cancers, and about the same percentage of non-Hodgkin's lymphomas.

What are some symptoms of pulmonary lymphoma?

Similar to other lymphomas, the symptoms associated with pulmonary lymphomas are non-specific and can be interpreted to be many different things. They are:

  • Fevers
  • Unexplained weight loss
  • Respiratory problems

Treatment and Prognosis of Pulmonary lymphoma

Because this cancer is so rare, the optimal treatment for pulmonary lymphoma remains in dispute. However, it is most commonly treated with R-CHOP combination chemotherapy or CHOP-related chemotherapy. The efficacy of surgical resection of the tumor has not been confirmed as a reliable therapeutic response.

That said, the median survival for patients with high-grade primary pulmonary lymphoma is around 8-10 years, provided the patient isn't immunocompromised by, for example, HIV infection.

Sources:

  • Cadranel J, Wislez M, Antoine M. "Primary pulmonary lymphoma." Eur Respir J 2002;20(3):750-762.
  • Brown, S et al. "High-grade primary pulmonary B cell lymphoma presenting as a necrotic mass.(Teaching Cases of the Month)(Case study)." Respiratory Care. Daedalus Enterprises, Inc. 2011.

Photo: Pexels

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap